T. Schweighoffer et al., ONCOGENE EXPRESSION IN THYMOCYTES AFTER EMETINE TREATMENT OF MICE, Cellular & molecular biology research, 39(7), 1993, pp. 647-656
Emetine (33 mg/kg IP) was used as an immunosuppressive agent to inhibi
t thymic development. The specific and reversible effect of emetine on
the macromolecular biosynthesis of thymocytes provided an in vivo mod
el to investigate cellular differentiation. Cortical cells emigrated u
pon emetine administration at the early stage of inhibition of macromo
lecular synthesis, followed by a repopulation stage and differentiatio
n of the thymus. Early events of differentiation were measured by the
gene expression of oncogenes showing a gradual decrease of c-myc mRNA
level, a temporary decline in c-fos mRNA which was reversed at t = 72
h after emetine treatment. The two-fold increase in mRNA synthesis of
c-src oncogene after emetine treatment was paralleled by a fivefold ri
se in total tyrosine kinase activity. The concomitant appearance of an
M(r) = 60,000 protein at t = 96 h after emetine treatment may be an i
ndication of the involvement of specific proteins in thymic developmen
t.